Carnegie acted as Nordic Selling Agent in IPO of Y-mAbs Therapeutics, Inc.
Carnegie acted as Nordic Selling Agent in IPO of Y-mAbs Therapeutics, Inc. on NASDAQ Global...
Er du kunde hos os, får du adgang til vores internetbaserede informationssystemer, hvor du blandt andet kan følge udviklingen i din portefølje.
Er du kunde hos os, får du adgang til vores internetbaserede informationssystemer, hvor du blandt andet kan følge udviklingen i din portefølje.
Carnegie acted as Nordic Selling Agent in IPO of Y-mAbs Therapeutics, Inc. on NASDAQ Global...
Carnegie acted as sole financial adviser in the transaction consisting of 800,000 shares in SP...
Carnegie acted as exclusive financial adviser to Matas in the acquisition of Firtal Group. Firtal...
Livförsäkringsbolaget Skandia divests all its Danish activities (‘Skandia’) to AP Pension. Skandia is the 7th...
Founded in 1967, GUBI is today a leading Danish design and interior company selling high-end...
Carnegie acted as joint bookrunner in the placing of 3.5 million shares in Boozt AB,...
Carnegie acted as joint bookrunner in the placing of 2.0 million shares in TCM Group,...
På foto ses fra venstre Lucas Eichild, tidligere Associate Director i Carnegie Investment Banking, formand...
Carnegie acted as exclusive financial adviser to Jyske Bank in the indirect sale of its...
Jyske Bank A/S (publ) (“Jyske Bank”) announced on 13 March 2018 plans to make a...
Carnegie acted as exclusive financial adviser to Santa Fe Group in obtaining a EUR 40...
Carnegie acted as exclusive financial adviser to H+H International (“H+H”) in the acquisition of Heidelberger...